Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial

Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial

Source: 
Stat
snippet: 

Aurinia Pharmaceuticals (AUPH) said Wednesday evening that an experimental medicine used to treat patients with lupus nephritis, an autoimmune kidney disease, achieved all primary and secondary efficacy goals in a late-stage clinical trial.